SCHEMBL20859554

SCHEMBL20859554

CC1C=CC([PH](C)(c2ccccc2)c2ccccc2)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12642868 0.70 — —
SCHEMBL23280225 0.67 NISCH (0.32) —
SCHEMBL22570845 0.67 — —
SCHEMBL8952 0.65 TSHR (0.39) —
SCHEMBL19593121 0.64 ALDH1A1 (0.32) —
SCHEMBL18725328 0.63 CYP3A4 (0.38) —
SCHEMBL18874589 0.63 EGFR (0.33) —
Bromide SCHEMBL647163 0.62 TSHR (0.37) —
SCHEMBL16034408 0.62 TSHR (0.37) —
SCHEMBL17431672 0.62 TSHR (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3461835-A1 CYCLOSPORINE ANALOGUE MOLECULES MODIFIED AT AMINO ACID 1 AND 3 ContraVir Pharmaceuticals, Inc. (US) 2019-04-03 — — EP disclosed
Send feedback